OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies
Puguang Yu, Chunming Zhu, Xiangyun You, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Puguang Yu, Chunming Zhu, Xiangyun You, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Showing 8 citing articles:
Optimizing rWTC-MBTA Vaccine Formulations, Dosing Regimens, and Cryopreservation Techniques to Enhance Anti-Metastatic Immunotherapy
Juan Ye, Herui Wang, Samik Chakraborty, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1340-1340
Open Access
Juan Ye, Herui Wang, Samik Chakraborty, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1340-1340
Open Access
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Global research progress in antibody-drug conjugates for solid tumors: Bibliometrics and visualized analysis
Wenjun Fang, Xueqing Ma, Ben Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Wenjun Fang, Xueqing Ma, Ben Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Lung Toxicity Occurring During Enfortumab Vedotin Treatment: From a Priming Case Report to a Retrospective Analysis
Grégoire Desimpel, François Zammit, Sarah Lejeune, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1547-1547
Open Access | Times Cited: 1
Grégoire Desimpel, François Zammit, Sarah Lejeune, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1547-1547
Open Access | Times Cited: 1
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
Guillermo Villacampa, Pablo Cresta Morgado, L. Carità, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102847-102847
Closed Access | Times Cited: 1
Guillermo Villacampa, Pablo Cresta Morgado, L. Carità, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102847-102847
Closed Access | Times Cited: 1
Emerging molecular therapies in the treatment of bladder cancer
Scott D. Bell, Anthony E. Quinn, Tom D. Spitzer, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1135-1154
Open Access
Scott D. Bell, Anthony E. Quinn, Tom D. Spitzer, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1135-1154
Open Access
Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives
Whi‐An Kwon, Min-Kyung Lee
Cancers (2024) Vol. 16, Iss. 23, pp. 4078-4078
Open Access
Whi‐An Kwon, Min-Kyung Lee
Cancers (2024) Vol. 16, Iss. 23, pp. 4078-4078
Open Access
